Alan D'Andrea

52PUBLICATIONS
277CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGenome structure and regulationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Nov 06, 2026
DNA-PK enforces the S/G2 checkpoint in ATM-deficient cells to limit ATR inhibitor efficacy.

|Nov 03, 2026
A Phase 1 Trial of Low-dose Gemcitabine Combined with ATR Inhibitor Elimusertib for Advanced Solid Tumors.

|Aug 24, 2026
A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

|Aug 14, 2026
Defective microhomology-mediated end joining in SMARCB1-deficient tumors.

|Mar 05, 2026
HPV16 E6 oncoprotein promotes microhomology-mediated viral integration by increasing PolΘ protein expression.

Guangli Zhu, Shuhei Asada, Jithma P Abeykoon

|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

Pageof 9

Frequent Collaborators

22 joint publications

Geoffrey I Shapiro

10 joint publications

Huy Nguyen

7 joint publications

Bose S Kochupurakkal

7 joint publications

Panagiotis A Konstantinopoulos